<DOC>
	<DOC>NCT00648869</DOC>
	<brief_summary>Single-dose, randomized, open-label, cross over study. The study will have an open-label, 3 period, 3 treatments, and randomized design. Each volunteer will receive a Metformin gum 2x250mg, Metformin gum 1x250mg &amp; Metformin tablet 500mg</brief_summary>
	<brief_title>Open-label Crossover Metformin Gum Versus Tablet in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Men ranging in age from 1840 Good general health as determined by medical history, physical examination, ECG, Blood pressure, and clinical laboratory tests (hematology &amp; clinical chemistry) obtained within 14 days prior to the start of the study. BMI &gt;18&amp;&lt;30. Willing and able to abide by the dietary requirements of the study. Willing and able to give written informed consent in a manner approved by the Ethics Committee. History of known or suspected clinically significant hypersensitivity to any drug. Any protocolrequired laboratory test abnormality that is considered clinically significant. Mentally unstable or incompetent. Any illness during the week before.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>pharmaceutical preparations</keyword>
</DOC>